Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity

Since dysregulation of intracellular calcium (Ca<sup>2+</sup>) levels is a common occurrence in neurodegenerative diseases, including Alzheimer’s disease (AD), the study of proteins that can correct neuronal Ca<sup>2+</sup> dysregulation is of great interest. In previous work...

Full description

Bibliographic Details
Main Authors: Maria Berrocal, Lucia Saez, Ana M. Mata
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/11/6055
_version_ 1797531468131467264
author Maria Berrocal
Lucia Saez
Ana M. Mata
author_facet Maria Berrocal
Lucia Saez
Ana M. Mata
author_sort Maria Berrocal
collection DOAJ
description Since dysregulation of intracellular calcium (Ca<sup>2+</sup>) levels is a common occurrence in neurodegenerative diseases, including Alzheimer’s disease (AD), the study of proteins that can correct neuronal Ca<sup>2+</sup> dysregulation is of great interest. In previous work, we have shown that plasma membrane Ca<sup>2+</sup>-ATPase (PMCA), a high-affinity Ca<sup>2+</sup> pump, is functionally impaired in AD and is inhibited by amyloid-β peptide (Aβ) and tau, two key components of pathological AD hallmarks. On the other hand, sorcin is a Ca<sup>2+</sup>-binding protein highly expressed in the brain, although its mechanism of action is far from being clear. Sorcin has been shown to interact with the intracellular sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA), and other modulators of intracellular Ca<sup>2+</sup> signaling, such as the ryanodine receptor or presenilin 2, which is closely associated with AD. The present work focuses on sorcin in search of new regulators of PMCA and antagonists of Aβ and tau toxicity. Results show sorcin as an activator of PMCA, which also prevents the inhibitory effects of Aβ and tau on the pump, and counteracts the neurotoxicity of Aβ and tau by interacting with them.
first_indexed 2024-03-10T10:44:14Z
format Article
id doaj.art-c2b669274d3a4755adec440b1c973063
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:44:14Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c2b669274d3a4755adec440b1c9730632023-11-21T22:44:07ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-06-012211605510.3390/ijms22116055Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump ActivityMaria Berrocal0Lucia Saez1Ana M. Mata2Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, SpainDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, SpainDepartamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias and Instituto de Biomarcadores de Patologías Moleculares, Universidad de Extremadura, 06006 Badajoz, SpainSince dysregulation of intracellular calcium (Ca<sup>2+</sup>) levels is a common occurrence in neurodegenerative diseases, including Alzheimer’s disease (AD), the study of proteins that can correct neuronal Ca<sup>2+</sup> dysregulation is of great interest. In previous work, we have shown that plasma membrane Ca<sup>2+</sup>-ATPase (PMCA), a high-affinity Ca<sup>2+</sup> pump, is functionally impaired in AD and is inhibited by amyloid-β peptide (Aβ) and tau, two key components of pathological AD hallmarks. On the other hand, sorcin is a Ca<sup>2+</sup>-binding protein highly expressed in the brain, although its mechanism of action is far from being clear. Sorcin has been shown to interact with the intracellular sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA), and other modulators of intracellular Ca<sup>2+</sup> signaling, such as the ryanodine receptor or presenilin 2, which is closely associated with AD. The present work focuses on sorcin in search of new regulators of PMCA and antagonists of Aβ and tau toxicity. Results show sorcin as an activator of PMCA, which also prevents the inhibitory effects of Aβ and tau on the pump, and counteracts the neurotoxicity of Aβ and tau by interacting with them.https://www.mdpi.com/1422-0067/22/11/6055sorcinplasma membrane Ca<sup>2+</sup>-ATPase (PMCA)amyloid-β peptidetaufunctional modulationneurodegeneration
spellingShingle Maria Berrocal
Lucia Saez
Ana M. Mata
Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
International Journal of Molecular Sciences
sorcin
plasma membrane Ca<sup>2+</sup>-ATPase (PMCA)
amyloid-β peptide
tau
functional modulation
neurodegeneration
title Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
title_full Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
title_fullStr Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
title_full_unstemmed Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
title_short Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer’s Disease on the Pump Activity
title_sort sorcin activates the brain pmca and blocks the inhibitory effects of molecular markers of alzheimer s disease on the pump activity
topic sorcin
plasma membrane Ca<sup>2+</sup>-ATPase (PMCA)
amyloid-β peptide
tau
functional modulation
neurodegeneration
url https://www.mdpi.com/1422-0067/22/11/6055
work_keys_str_mv AT mariaberrocal sorcinactivatesthebrainpmcaandblockstheinhibitoryeffectsofmolecularmarkersofalzheimersdiseaseonthepumpactivity
AT luciasaez sorcinactivatesthebrainpmcaandblockstheinhibitoryeffectsofmolecularmarkersofalzheimersdiseaseonthepumpactivity
AT anammata sorcinactivatesthebrainpmcaandblockstheinhibitoryeffectsofmolecularmarkersofalzheimersdiseaseonthepumpactivity